You are using an unsupported browser. Please upgrade your browser to a newer version to get the best experience on DrugBank.
Identification
NameCholecalciferol
Accession NumberDB00169  (NUTR00008, APRD00506)
TypeSmall Molecule
GroupsApproved, Nutraceutical
DescriptionDerivative of 7-dehydroxycholesterol formed by ultraviolet rays breaking of the C9-C10 bond. It differs from ergocalciferol in having a single bond between C22 and C23 and lacking a methyl group at C24. [PubChem]
Structure
Thumb
Synonyms
(+)-vitamin D3
(1S,3Z)-3-[(2e)-2-[(1R,3AR,7as)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexan-1-ol
(3beta,5Z,7e)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
(5Z,7e)-(3S)-9,10-Secocholesta-5,7,10(19)-trien-3-ol
Activated 7-dehydrocholesterol
calciol
CC
Cholecalciferol
Colecalciferol
delta-D
Oleovitamin D3
Vitamin D3
External Identifiers Not Available
Approved Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Cataplex D Tab 400unitTablet400 unitOralStandard Process Inc.Not applicableNot applicableCanada
Euro D 10000Capsule10000 unitOralSandoz Canada Incorporated2005-04-06Not applicableCanada
Formula 3200 Waf 100unitWafer100 unitOralStandard Process Inc.Not applicableNot applicableCanada
Jamp-vitamin DCapsule5000 unitOralJamp Pharma CorporationNot applicableNot applicableCanada
Jamp-vitamin DCapsule25000 unitOralJamp Pharma CorporationNot applicableNot applicableCanada
Jamp-vitamin DCapsule2000 unitOralJamp Pharma CorporationNot applicableNot applicableCanada
Jamp-vitamin DCapsule10000 unitOralJamp Pharma Corporation2015-11-20Not applicableCanada
Jamp-vitamin DCapsule50000 unitOralJamp Pharma Corporation2016-06-23Not applicableCanada
Pharma-D 10000 IuCapsule10000 unitOralPharmascience Inc2011-08-29Not applicableCanada
Pharma-D 5000 IuCapsule5000 unitOralPharmascience IncNot applicableNot applicableCanada
Pharma-D 50000 IuCapsule50000 unitOralPharmascience Inc2011-08-09Not applicableCanada
Vitamin D3-softgel CapsulesCapsule100000 unitOralOrimed Pharma IncNot applicableNot applicableCanada
Vitamin D3-softgel Capsules 10000 IuCapsule10000 unitOralOrimed Pharma Inc2015-10-20Not applicableCanada
Vitamin D3-softgel Capsules 2000 IuCapsule2000 unitOralOrimed Pharma Inc2015-07-31Not applicableCanada
Vitamin D3-softgel Capsules 25000 IuCapsule25000 unitOralOrimed Pharma Inc2015-07-31Not applicableCanada
Vitamin D3-softgel Capsules 5000 IuCapsule5000 unitOralOrimed Pharma Inc2015-10-20Not applicableCanada
Vitamin D3-softgel Capsules 50000 IuCapsule50000 unitOralOrimed Pharma Inc2015-10-20Not applicableCanada
Approved Generic Prescription ProductsNot Available
Approved Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
D Vi Sol Infants Drops 400unit/0.6mlSolution / drops400 unitOralMead Johnson Nutritionals1985-12-311998-09-28Canada
Vitamin D 1000iuTablet1000 unitOralWn Pharmaceuticals Ltd.1999-07-082007-08-07Canada
Vitamin D 400 IuTablet400 unitOralWn Pharmaceuticals Ltd.2002-03-132007-08-07Canada
Vitamin D 400 Iu TabletsTablet400 unitOralSwiss Herbal Remedies Ltd.1996-12-112009-08-04Canada
Vitamin D-dry 400 I.U.Tablet400 unitOralGreat Earth Companies, Inc.1998-08-252002-10-02Canada
Unapproved/Other Products Not Available
International Brands
NameCompany
Micro-DNot Available
Optimal-DRV Nutritional, LLC
VigantolNot Available
Brand mixtures
NameLabellerIngredients
A + D OintmentNational Care Products Ltd.
A.R.T.H. Away FormulaAbundance Marketing Ltd.
Acti-cal/mag 2:1 + Zinc and D CapletActi Form Ltd.
Actical Plus Calcium-magnesium-vitamin D3-silicon ChewableUsana Health Sciences Inc.
Active Calcium Plus Magnesium, Vitamin D and SiliconUsana Health Sciences Inc.
Active FeGm Pharmaceuticals, Inc.
Actonel Sachet KitWarner Chilcott Canada Co
AdrovanceMerck Sharp & Dohme Ltd
Alendronate-cholecalciferolFrosst A Division Of Merck Canada Inc
Animi-3PBM Pharmaceuticals, Inc
Animi-3 With Vitamin DPBM Pharmaceuticals, Inc
Antiseptic Skin CreamArjohuntleigh Canada Inc.
ApcalA P J Laboratories Limited
Apo-alendronate/vitamin D3Apotex Inc
Avon Nutrivance Soft Calcium Chews With Vitamin DAvon Canada Ulc
Beta Carotene Provitamin A With DGahler Enterprises Ltd.
C-nate DHACenturion Labs, Llc
C.H.V. FormulaNihon Kenko Zoushin Kenkyukai Canada Inc., Subsidery Of Nikken Usa Inc.
Cal-mag Citrate Zinc & Vitamin D TabletsSwiss Herbal Remedies Ltd.
Cal-mag Complete With Zinc, C and DQuest Vitamins A Div Of Purity Life Health Products
Cal-mag With Zinc & Vitamin DHealth Wise Nutrition Inc.
Cal/mag 1:1 With Zinc and Vitamin D - TabletHealth Wise Nutrition Inc.
Calci-yum Plus Magnesium + D3Nu Life Nutrition Ltd.
Calcium & Magnesium Citrate Plus D With Manganese, Potassium & ZincNatural Factors Nutritional Products Ltd.
Calcium & Magnesium With Potassium, Zinc, Manganese & Vitamin DWn Pharmaceuticals Ltd.
Calcium & Vitamin DQuantofill Inc.
Calcium 250 Mg With Vitamin DGfr Pharma Ltd.
Calcium 600 + DLaboratoire Riva Inc
Calcium 600mg + Vit D3 125unit TabPharmetics (2011) Inc
Calcium and Magnesium 1:1 Plus TabletsAlbi Naturals
Calcium and Magnesium Citrate and Vitamin D 250mg/125mg/200iuWn Pharmaceuticals Ltd.
Calcium and Magnesium With Vitamin DVita Health Products Inc
Calcium Citrate and Vitamin D 200mg/160iuWn Pharmaceuticals Ltd.
Calcium Citrate With Vitamin DWn Pharmaceuticals Ltd.
Calcium Complex High GradeNew Spirit Naturals, Inc.
Calcium Et Magnesium Plus Vitamin DLaboratoire Lalco Inc.
Calcium Folic Acid Plus D ChewableAcella Pharmaceuticals, LLC
Calcium With Mg Zn Mn Cu CR Si and Vit. C & DJamieson Laboratories Ltd
Calcium With Vitamin D 200 Mg/160 IuWn Pharmaceuticals Ltd.
Calcium-magnesium With K & Zn and Vitamin D3Holista Health (Canada) Inc.
Calcium/magnesium/vitamin D - CapsuleHolista Health (Canada) Inc.
Calma-DWn Pharmaceuticals Ltd.
CalplusLifestyles Canada Corporation
Caltrate 600 Plus D - TabletWhitehall Robins Inc.
Chela Calmag-100 Plus Zinc D3Nu Life Nutrition Ltd.
Chela Calmag-300 Plus Zinc D3Nu Life Nutrition Ltd.
Chewable MultivitaminsWn Pharmaceuticals Ltd.
Chewable Multivitamins Plus IronWn Pharmaceuticals Ltd.
Children Choice Multivit Chewable TabSwiss Herbal Remedies Ltd.
Children Choice Multivitamin W Iron Chew TabSwiss Herbal Remedies Ltd.
Children Vitamin DropsWampole Brands, A Division Of Pangeo Pharma (Canada) Inc.
Children's Chewable Multi-vitaminWn Pharmaceuticals Ltd.
Children's Chewable Multi-vitamin Complete With MineralsWn Pharmaceuticals Ltd.
Children's Chewable Multiple Vit.plus IronStanley Pharmaceuticals, A Division Of Vita Health Products Inc.
Children's Chewable Multiple Vitamins - TabStanley Pharmaceuticals, A Division Of Vita Health Products Inc.
Children's Vitamins ChewableVita Health Products Inc
Children's Vitamins W Iron ChewableVita Health Products Inc
Childrens Chewable Vitamin TabPharmetics (2011) Inc
Childrens Chewable VitaminsGarden State Nutritionals
CiferexAdler Stern Pharmaceuticals, Llc
Citranatal B-calmMission Pharmacal Company
Citranatal Harmony 3.0Mission Pharmacal Company
Cod Liver Oil Oleovitamin A & D Caps 20minNutricorp International
Cod Liver Oil USPNu Life Nutrition Ltd.
Coral Calcium Plus Vitamin D 210mg/100iuWn Pharmaceuticals Ltd.
Derma-forcePrairie Naturals
Dry Super Vitamin A Plus D - CapGeneral Nutrition Canada Inc.
DuracholSterling Knight Pharmaceuticals,Llc
Efferlife Calcium 500mg + Vitamin D3 440 Iu + Vitamin C 125mgNaturale Science Inc.
Efferlife Multivitamins and MineralsNaturale Science Inc.
Enviroflex - TabEnviro Tech International Canada
EscaviteGm Pharmaceuticals, Inc.
Extra P.N. Vitamin-mineral Drink MixChanges International
Extra-virt Plus DHAVirtus Pharmaceuticals LLC
FlorivaBon Geo Pharmaceuticals, Inc.
Floriva PlusBon Geo Pharmaceuticals, Inc.
Folcaps Care OneMidlothian Laboratories
Folcaps Omega-3Midlothian Laboratories
Folet OnePronova Corporation
Foltabs PrenatalMidlothian Laboratories
For Kids Only Chewable Multivit. Plus IronKsl Pharmaceuticals
For Kids Only Chewable Multivitamins - TabKsl Pharmaceuticals
Formula O-care Vitamin and Mineral SupplementFor Mor International Inc.
Formula OsgSeroyal International Inc.
Fortamines 10 CapsulesRougier Pharma Division Of Ratiopharm Inc
Fortamines-10 ComprimesRougier Pharma Division Of Ratiopharm Inc
Forty Plus Vitamin SupplementGarden State Nutritionals
Fosamax Plus DMerck Sharp & Dohme Corp.
FosavanceMerck Canada Inc
G.A.S. ComplexAbundance Marketing Ltd.
Garfield Chewable Multivits Plus Iron TabWhitehall Robins Inc.
Gestamine ComprimesLab Nadeau LtÉe, Division Of Technilab Inc.
Gesticare DHAJazz Pharmaceuticals Commercial Corp.
Healthy Mamabe Well Rounded Be Well RoundedMATERNAL SCIENCE, LLC
Hemenatal OBWh Nutritionals, Llc
Hormodausse Plus Calc Et D TabLaboratoires Charton Laboratories
Hvp Chelated Cal/mag With Zinc and Vitamins C and DDarwen Holdings Ltd.
Inatal AdvanceNnodum Pharmaceuticals
Inatal UltraNnodum Pharmaceuticals
Infant Multivitamin DropsGeneral Nutrition Canada Inc.
IpricalPep Products Inc.
Iron Polysaccharides Folic Acid DHAVirtus Pharmaceuticals LLC
Isotonix Calcium Plus FormulaMarket America, Inc.
Kid's Choice Children's Chewable Vitamins - TabVita Health Products Inc
Kids Stuff TabletsVita Health Products Inc
Kids Stuff With Iron TabletsVita Health Products Inc
Kimchi Vitamin Chewable MultivitaminTobico
Liqui Cal-DTwin Laboratories Inc.
Liquid Cal/mag Plus DGahler Enterprises Ltd.
Liquid Calcium and Magnesium With Vit.dRheingold Food International Ltd.
MagnacalHolista Health (Canada) Inc.
Menocal TabLes Aliments Nutri Source Inc.
Mid-life Magnacal 2Holista Health (Canada) Inc.
Mor-vites TabPharmetics (2011) Inc
Multi - N.T.O.x Formula - TabAbundance Marketing Ltd.
Multi Vitamin - MineralEnrich International
Multi Vitamin & MineralsWn Pharmaceuticals Ltd.
Multi Vitamin and FluorideLibertas Pharma, Inc.
Multi Vitamin Drops With FluorideSeton Pharmaceuticals
Multi Vitamin Drops With Fluoride and IronSeton Pharmaceuticals
Multi Vitamin Drops With Fluoride With IronStratus Pharmaceuticals
Multi Vitamin Plus IronWn Pharmaceuticals Ltd.
Multi Vitamin With FluorideQualitest Pharmaceuticals
Multi Vitamin, Iron and FluorideLibertas Pharma, Inc.
Multi Vitamins & MineralsWn Pharmaceuticals Ltd.
Multi-vit With FluorideA S Medication Solutions Llc
Multi-vit With Fluoride and IronQualitest Pharmaceuticals
Multi-vitamin Dietary SupplementGarden State Nutritionals
Multi-vitamin FluorideStratus Pharmaceuticals
Multi-vitamin Fluoride and Iron DropsBoca Pharmacal, LLC
Multi-vitamin Fluoride DropsH.J. Harkins Company, Inc.
Multi-vitamin With FluorideLibertas Pharma, Inc.
Multi-vitaminsWn Pharmaceuticals Ltd.
Multi-vitamins With MineralsWn Pharmaceuticals Ltd.
Multiple VitaminsGfr Pharma Ltd.
MultivitaminLaboratoires Confab Inc
Multivitamin With FluoridePure Tek Corporation
Multivitamines Plus Fer Pour Enfants (chewable Tablets)Laboratoire Lalco Inc.
Multivitamines Pour Enfants (chewable Tablets)Laboratoire Lalco Inc.
Multivitamins for ChildrenQuest Vitamins A Div Of Purity Life Health Products
MvcSancilio & Company Inc
Nata KompleteWh Nutritionals, Llc
NatafortMission Pharmacal Company
NataviteSchein Pharmaceutical Canada Inc.
Neo-vites & Minerals TabNeolab Inc
Nexa PlusUpsher Smith Laboratories, Inc.
Nexa Select Rx Prenatal Vitamin With Plant-based DHAUpsher Smith Laboratories, Inc.
NuferaCar Win Pharmaceutical Associates, Llc
Nutri-chem Calcium Magnesium With D and ZincNutri Chem Pharmacy Ltd
Nutrifer Plus TabletsWyeth Ayerst Canada Inc.
Nutrilite Double XNutrilite, A Division Of Access Business Group, Llc
O Calcium 500mg Plus D TabVita Health Products Inc
O-cal Fa MultivitaminPharmics, Inc.
O-cal Prenatal VitaminPharmics, Inc.
O-calcium 250mg Plus DVita Health Products Inc
Opti-cal Chewable +d CapletNu Life Nutrition Ltd.
Orifer FSanofi Aventis Canada Inc
Osteo FormulaNutramed Laboratories Inc.
Osteo Formula TabQuest Vitamins A Div Of Purity Life Health Products
Osteo TabletsQuest Vitamins A Div Of Purity Life Health Products
Osteo-lifeViva Pharmaceutical Inc.
Osteo-plusRolmex International Inc.
Oyster Shell Calcium With Vitamin DCardinal Health
P.N.P. Vitamin DrinkChanges International
P.R.O. ComplexAbundance Marketing Ltd.
Paramettes Chewable Multivitamins Plus IronWyeth Ayerst Canada Inc.
Paramettes Chewable Multivits With Iron TabWhitehall Robins Inc.
Paramettes Multivits Plus Iron Tab (teens)Whitehall Robins Inc.
PM CapsNew Vision Nutritionals Company
PNF-FirstAcella Pharmaceuticals, LLC
Pnv Ferrous Fumarate Docusate Folic AcidVirtus Pharmaceuticals LLC
Pnv Prenatal Plus MultivitaminSancilio & Company Inc
Pnv Prenatal VitaminSancilio & Company Inc
Pnv Prenatal Vitamin Plus Vitamin ASancilio & Company Inc
Pnv-dhaAcella Pharmaceuticals, LLC
Pnv-selectAcella Pharmaceuticals, LLC
Port A Mins Super Cal-mag 300/150 With Vitamin D3Great Earth Companies, Inc.
Port A Mins Super Calcium 375 With Vitamin D3Great Earth Companies, Inc.
Port A Mins Super Calcium 750 With Vitamin D3Great Earth Companies, Inc.
Prefera Ob Plus DHAAlaven Pharmaceutical LLC
PreferaobMEDA Pharmaceuticals
Preferaob OneMEDA Pharmaceuticals
Preferaob Plus DHAAlaven Pharmaceutical LLC
PregvitDuchesnay Inc
Pregvit Folic 4Duchesnay Inc
Pregvit Folic 5Duchesnay Inc
PrenaissanceAcella Pharmaceuticals, LLC
Prenaissance PlusAcella Pharmaceuticals, LLC
Prenatal 19Nationwide Laboratories, LLC
Prenatal PlusBlenheim Pharmacal, Inc.
Prenatal Plus IronMajor Pharmaceuticals
Prenatal Vitamins Plusbryant ranch prepack
Prenatal Vitamins Plus Low IronPatrin Pharma, Inc.
Prenate EliteAvion Pharmaceuticals, Llc
Prenate EnhanceAvion Pharmaceuticals, Llc
Prenate EssentialAvion Pharmaceuticals, Llc
Prenate PixieAvion Pharmaceuticals, Llc
Prenate RestoreAvion Pharmaceuticals, Llc
Prenate StarAvion Pharmaceuticals, Llc
PreplusVirtus Pharmaceuticals LLC
PretabVirtus Pharmaceuticals LLC
Prevital TabBio Vita
Pure Calcium CalciumSaimdang Cosmetics Co., Ltd
Q.T. Vitamin and Mineral Drink MixGarden State Nutritionals
Redoxon-calBayer Inc Consumer Care
RevestaSterling Knight Pharmaceuticals,Llc
Sandoz Alendronate/cholecalciferolSandoz Canada Incorporated
Se-care ChewableSeton Pharmaceuticals
Se-natal 19Seton Pharmaceuticals
Se-natal 19 ChewableSeton Pharmaceuticals
Se-natal OneSeton Pharmaceuticals
Sincera - TabletsScandinavian Formulas Inc.
Strovite One CapletsEverett Laboratories, Inc.
Sun-rype VitaburstSun Rype Products Ltd.
Super Cal Mag PlusShaklee Canada Inc
Super Charged EnergySimone Protective Pharmaceuticals, Inc.
Super-pote Vitamin SupplementGarden State Nutritionals
Supplement De Vitamines Et MinerauxLand Art Inc.
Supplements De Vitamines Et MinerauxLand Art Inc.
T-PA CapSeroyal International Inc.
T.A. Vit A & D OintmentJamieson Laboratories Ltd
Teva-alendronate/cholecalciferolTeva Canada Limited
TozalFocus Laboratories, Inc.
Tri Vi Flor TabMead Johnson Nutritionals
Tri-VI-sol DropsMead Johnson Nutritionals
Tri-vit With Fluoride and Iron DropsQualitest Pharmaceuticals
Tri-vit With Fluoride DropsA S Medication Solutions Llc
TriadvanceTrigen Laboratories, Inc.
Tricare PrenatalMedecor Pharma, Llc
Trinatal GtTrigen Laboratories, Inc.
Triple Vitamin Drops With FluorideStratus Pharmaceuticals
Triple-vitamin Drops With FluorideBoca Pharmacal, LLC
Ultimatecare One NfTrigen Laboratories, Inc.
Usana Active CalciumUsana Health Sciences, Inc.
Usana Calmag Plus Tablets - TabUsana Health Sciences Inc.
Usana Megavitamin Tablets - TabUsana Health Sciences Inc.
Usana Optimizer Actical Plus Calcium-magnesium-vitamin D3-silicon TabletsUsana Health Sciences Inc.
V-natalVirtus Pharmaceuticals
Virt-bal DHA PlusVirtus Pharmaceuticals
Virt-PNVirtus Pharmaceuticals
Virt-PN DHAVirtus Pharmaceuticals
Virt-PN PlusVirtus Pharmaceuticals LLC
Vita Day TabJamieson Laboratories Ltd
Vitafol NanoEverett Laboratories, Inc.
Vitafol UltraEverett Laboratories, Inc.
Vitamin D3dietary Supplemen Dietary SupplementNnodum Pharmaceuticals
Vitamines A - D CalciumLaboratoire Lalco Inc.
Vitamins A, C, D and FluorideLibertas Pharma, Inc.
Vp Ch PlusVirtus Pharmaceuticals LLC
Vp Ch UltraVirtus Pharmaceuticals LLC
Vp-CH-pnvVirtus Pharmaceuticals
VP-heme OBVirtus Pharmaceuticals LLC
VP-heme OneVirtus Pharmaceuticals LLC
Vtb Vitamin and Mineral SupplementGarden State Nutritionals
Women's FormulaPro Ma Systems
Women's Support TabletsGeneral Nutrition Canada Inc.
Zatean-CHTrigen Laboratories, Inc.
ZavaraMisemer Pharmaceuticals, Inc.
ZolateAxiom Pharma
SaltsNot Available
Categories
UNII1C6V77QF41
CAS number67-97-0
WeightAverage: 384.6377
Monoisotopic: 384.33921603
Chemical FormulaC27H44O
InChI KeyQYSXJUFSXHHAJI-YRZJJWOYSA-N
InChI
InChI=1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13-/t21-,24+,25-,26+,27-/m1/s1
IUPAC Name
(1S,3Z)-3-{2-[(1R,3aS,4E,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexan-1-ol
SMILES
CC(C)CCC[C@@H](C)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)CCC1=C
Pharmacology
IndicationFor the treatment of vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis.
Structured Indications Not Available
PharmacodynamicsCholecalciferol (vitamin D3) is a steroid hormone that has long been known for its important role in regulating body levels of calcium and phosphorus, in mineralization of bone, and for the assimilation of Vitamin A. The classical manifestations of vitamin D deficiency is rickets, which is seen in children and results in bony deformaties including bowed long bones. Deficiency in adults leads to the disease osteomalacia. Both rickets and osteomalacia reflect impaired mineralization of newly synthesized bone matrix, and usually result from a combination of inadequate exposure to sunlight and decreased dietary intake of vitamin D. Common causes of vitamin D deficiency include genetic defects in the vitamin D receptor, severe liver or kidney disease, and insufficient exposure to sunlight. Vitamin D plays an important role in maintaining calcium balance and in the regulation of parathyroid hormone (PTH). It promotes renal reabsorption of calcium, increases intestinal absorption of calcium and phosphorus, and increases calcium and phosphorus mobilization from bone to plasma.
Mechanism of actionThe first step involved in the activation of vitamin D3 is a 25-hydroxylation which is catalysed by the 25-hydroxylase in the liver and then by other enzymes. The mitochondrial sterol 27-hydroxylase catalyses the first reaction in the oxidation of the side chain of sterol intermediates. The active form of vitamin D3 (calcitriol) binds to intracellular receptors that then function as transcription factors to modulate gene expression. Like the receptors for other steroid hormones and thyroid hormones, the vitamin D receptor has hormone-binding and DNA-binding domains. The vitamin D receptor forms a complex with another intracellular receptor, the retinoid-X receptor, and that heterodimer is what binds to DNA. In most cases studied, the effect is to activate transcription, but situations are also known in which vitamin D suppresses transcription. Calcitriol increases the serum calcium concentrations by: increasing GI absorption of phosphorus and calcium, increasing osteoclastic resorption, and increasing distal renal tubular reabsorption of calcium. Calcitriol appears to promote intestinal absorption of calcium through binding to the vitamin D receptor in the mucosal cytoplasm of the intestine. Subsequently, calcium is absorbed through formation of a calcium-binding protein.
TargetKindPharmacological actionActionsOrganismUniProt ID
Vitamin D3 receptorProteinyes
agonist
HumanP11473 details
Related Articles
AbsorptionReadily absorbed
Volume of distributionNot Available
Protein binding50% to 80%
Metabolism

Within the liver, cholecalciferal is hydroxylated to calcidiol (25-hydroxycholecalciferol) by the enzyme 25-hydroxylase. Within the kidney, calcidiol serves as a substrate for 1-alpha-hydroxylase, yielding calcitriol (1,25-dihydroxycholecalciferol), the biologically active form of vitamin D3.

SubstrateEnzymesProduct
Cholecalciferol
Not Available
(23S)-23,25-dihdroxy-24-oxovitamine D3 23-(beta-glucuronide)Details
Route of eliminationNot Available
Half lifeSeveral weeks
ClearanceNot Available
ToxicityHypercalcemia - Early symptoms of hypercalcemia, include nausea and vomiting, weakness, headache, somnolence, dry mouth, constipation, metallic taste, muscle pain and bone pain. Late symptoms and signs of hypercalcemia, include polyuria, polydipsia, anorexia, weight loss, nocturia, conjunctivitis, pancreatitis, photophobia, rhinorrhea, pruritis, hyperthermia, decreased libido, elevated BUN, albuminuria, hypercholesterolemia, elevated ALT (SGPT) and AST (SGOT), ectopic calcification, nephrocalcinosis, hypertension and cardiac arrhythmias.
Affected organisms
  • Humans and other mammals
Pathways
PathwayCategorySMPDB ID
Alendronate Action PathwayDrug actionSMP00095
Zoledronate Action PathwayDrug actionSMP00107
Wolman diseaseDiseaseSMP00511
Pravastatin Action PathwayDrug actionSMP00089
Risedronate Action PathwayDrug actionSMP00112
HypercholesterolemiaDiseaseSMP00209
Rosuvastatin Action PathwayDrug actionSMP00092
Fluvastatin Action PathwayDrug actionSMP00119
CHILD SyndromeDiseaseSMP00387
Hyper-IgD syndromeDiseaseSMP00509
Cerivastatin Action PathwayDrug actionSMP00111
Pamidronate Action PathwayDrug actionSMP00117
Atorvastatin Action PathwayDrug actionSMP00131
Cholesteryl ester storage diseaseDiseaseSMP00508
Mevalonic aciduriaDiseaseSMP00510
Steroid BiosynthesisMetabolicSMP00023
Ibandronate Action PathwayDrug actionSMP00079
Simvastatin Action PathwayDrug actionSMP00082
Lovastatin Action PathwayDrug actionSMP00099
Lysosomal Acid Lipase Deficiency (Wolman Disease)DiseaseSMP00319
DesmosterolosisDiseaseSMP00386
Chondrodysplasia Punctata II, X Linked Dominant (CDPX2)DiseaseSMP00388
Smith-Lemli-Opitz Syndrome (SLOS)DiseaseSMP00389
SNP Mediated EffectsNot Available
SNP Mediated Adverse Drug ReactionsNot Available
Interactions
Drug Interactions
DrugInteractionDrug group
4-MethoxyamphetamineThe metabolism of 4-Methoxyamphetamine can be decreased when combined with Cholecalciferol.Experimental, Illicit
AceclofenacThe metabolism of Aceclofenac can be decreased when combined with Cholecalciferol.Approved
AcenocoumarolThe metabolism of Acenocoumarol can be decreased when combined with Cholecalciferol.Approved
AcetaminophenThe metabolism of Acetaminophen can be decreased when combined with Cholecalciferol.Approved
AcetylcholineThe metabolism of Acetylcholine can be decreased when combined with Cholecalciferol.Approved
AcetyldigitoxinCholecalciferol may increase the arrhythmogenic activities of Acetyldigitoxin.Approved
Acetylsalicylic acidThe metabolism of Acetylsalicylic acid can be decreased when combined with Cholecalciferol.Approved, Vet Approved
AdinazolamThe metabolism of Adinazolam can be decreased when combined with Cholecalciferol.Approved
AjmalineThe metabolism of Ajmaline can be decreased when combined with Cholecalciferol.Approved
AlfacalcidolThe risk or severity of adverse effects can be increased when Cholecalciferol is combined with Alfacalcidol.Approved, Nutraceutical
AlmotriptanThe metabolism of Almotriptan can be decreased when combined with Cholecalciferol.Approved, Investigational
AlogliptinThe metabolism of Alogliptin can be decreased when combined with Cholecalciferol.Approved
AlosetronThe metabolism of Alosetron can be decreased when combined with Cholecalciferol.Approved, Withdrawn
AlprazolamThe metabolism of Alprazolam can be decreased when combined with Cholecalciferol.Approved, Illicit, Investigational
AlprenololThe metabolism of Alprenolol can be decreased when combined with Cholecalciferol.Approved, Withdrawn
Aluminum hydroxideThe serum concentration of Aluminum hydroxide can be increased when it is combined with Cholecalciferol.Approved
AmbrisentanThe metabolism of Ambrisentan can be decreased when combined with Cholecalciferol.Approved, Investigational
AminophenazoneThe metabolism of Aminophenazone can be decreased when combined with Cholecalciferol.Approved, Withdrawn
AmiodaroneThe metabolism of Cholecalciferol can be decreased when combined with Amiodarone.Approved, Investigational
AmitriptylineThe metabolism of Amitriptyline can be decreased when combined with Cholecalciferol.Approved
AmodiaquineThe serum concentration of Amodiaquine can be increased when it is combined with Cholecalciferol.Approved
AmoxapineThe metabolism of Amoxapine can be decreased when combined with Cholecalciferol.Approved
AmoxicillinThe metabolism of Amoxicillin can be decreased when combined with Cholecalciferol.Approved, Vet Approved
AmphetamineThe metabolism of Amphetamine can be decreased when combined with Cholecalciferol.Approved, Illicit
AmprenavirThe metabolism of Amprenavir can be decreased when combined with Cholecalciferol.Approved
AmsacrineThe metabolism of Amsacrine can be decreased when combined with Cholecalciferol.Approved
AntipyrineThe metabolism of Antipyrine can be decreased when combined with Cholecalciferol.Approved
AnvirzelCholecalciferol may increase the arrhythmogenic activities of Anvirzel.Investigational
ApixabanThe metabolism of Apixaban can be decreased when combined with Cholecalciferol.Approved
AprepitantThe serum concentration of Cholecalciferol can be increased when it is combined with Aprepitant.Approved, Investigational
AprindineThe metabolism of Aprindine can be decreased when combined with Cholecalciferol.Approved
Arachidonic AcidThe metabolism of Arachidonic Acid can be decreased when combined with Cholecalciferol.Experimental
ArformoterolThe metabolism of Arformoterol can be decreased when combined with Cholecalciferol.Approved, Investigational
AripiprazoleThe serum concentration of Aripiprazole can be increased when it is combined with Cholecalciferol.Approved, Investigational
ArtemetherThe metabolism of Artemether can be decreased when combined with Cholecalciferol.Approved
AstemizoleThe metabolism of Astemizole can be decreased when combined with Cholecalciferol.Approved, Withdrawn
AtazanavirThe metabolism of Cholecalciferol can be decreased when combined with Atazanavir.Approved, Investigational
AtomoxetineThe metabolism of Cholecalciferol can be decreased when combined with Atomoxetine.Approved
AxitinibThe metabolism of Axitinib can be decreased when combined with Cholecalciferol.Approved, Investigational
AzelastineThe metabolism of Azelastine can be decreased when combined with Cholecalciferol.Approved
BendroflumethiazideBendroflumethiazide may increase the hypercalcemic activities of Cholecalciferol.Approved
BenzatropineThe metabolism of Benzatropine can be decreased when combined with Cholecalciferol.Approved
Benzyl alcoholThe metabolism of Benzyl alcohol can be decreased when combined with Cholecalciferol.Approved
BepridilThe metabolism of Bepridil can be decreased when combined with Cholecalciferol.Approved, Withdrawn
BetaxololThe metabolism of Betaxolol can be decreased when combined with Cholecalciferol.Approved
BexaroteneThe serum concentration of Cholecalciferol can be decreased when it is combined with Bexarotene.Approved, Investigational
BisoprololThe metabolism of Bisoprolol can be decreased when combined with Cholecalciferol.Approved
BoceprevirThe metabolism of Cholecalciferol can be decreased when combined with Boceprevir.Approved
BortezomibThe metabolism of Cholecalciferol can be decreased when combined with Bortezomib.Approved, Investigational
BosentanThe serum concentration of Bosentan can be increased when it is combined with Cholecalciferol.Approved, Investigational
BrexpiprazoleThe serum concentration of Brexpiprazole can be increased when it is combined with Cholecalciferol.Approved
BromazepamThe metabolism of Bromazepam can be decreased when combined with Cholecalciferol.Approved, Illicit
BrompheniramineThe metabolism of Brompheniramine can be decreased when combined with Cholecalciferol.Approved
BufuralolThe metabolism of Bufuralol can be decreased when combined with Cholecalciferol.Experimental, Investigational
BupivacaineThe metabolism of Bupivacaine can be decreased when combined with Cholecalciferol.Approved, Investigational
BuprenorphineThe metabolism of Buprenorphine can be decreased when combined with Cholecalciferol.Approved, Illicit, Investigational, Vet Approved
BupropionThe metabolism of Bupropion can be decreased when combined with Cholecalciferol.Approved
BuspironeThe metabolism of Buspirone can be decreased when combined with Cholecalciferol.Approved, Investigational
CabozantinibThe metabolism of Cabozantinib can be decreased when combined with Cholecalciferol.Approved
CaffeineThe metabolism of Caffeine can be decreased when combined with Cholecalciferol.Approved
CalcidiolThe risk or severity of adverse effects can be increased when Calcidiol is combined with Cholecalciferol.Approved, Nutraceutical
CalcipotriolThe risk or severity of adverse effects can be increased when Cholecalciferol is combined with Calcipotriol.Approved
CalcitriolThe risk or severity of adverse effects can be increased when Calcitriol is combined with Cholecalciferol.Approved, Nutraceutical
CalciumThe risk or severity of adverse effects can be increased when Calcium is combined with Cholecalciferol.Nutraceutical
Calcium AcetateThe risk or severity of adverse effects can be increased when Calcium Acetate is combined with Cholecalciferol.Approved
Calcium carbonateThe risk or severity of adverse effects can be increased when Calcium carbonate is combined with Cholecalciferol.Approved
Calcium ChlorideThe risk or severity of adverse effects can be increased when Calcium Chloride is combined with Cholecalciferol.Approved
Calcium citrateThe risk or severity of adverse effects can be increased when Calcium citrate is combined with Cholecalciferol.Approved
Calcium glubionateThe risk or severity of adverse effects can be increased when Calcium glubionate is combined with Cholecalciferol.Approved
Calcium GluceptateThe risk or severity of adverse effects can be increased when Calcium Gluceptate is combined with Cholecalciferol.Approved
Calcium gluconateThe risk or severity of adverse effects can be increased when Calcium gluconate is combined with Cholecalciferol.Approved, Vet Approved
CandesartanThe metabolism of Candesartan can be decreased when combined with Cholecalciferol.Approved
CaptoprilThe metabolism of Captopril can be decreased when combined with Cholecalciferol.Approved
CarbamazepineThe metabolism of Cholecalciferol can be increased when combined with Carbamazepine.Approved, Investigational
CarbinoxamineThe metabolism of Carbinoxamine can be decreased when combined with Cholecalciferol.Approved
CariprazineThe metabolism of Cariprazine can be decreased when combined with Cholecalciferol.Approved
CarisoprodolThe metabolism of Carisoprodol can be decreased when combined with Cholecalciferol.Approved
CarteololThe metabolism of Carteolol can be decreased when combined with Cholecalciferol.Approved
CarvedilolThe serum concentration of Carvedilol can be increased when it is combined with Cholecalciferol.Approved, Investigational
CelecoxibThe metabolism of Celecoxib can be decreased when combined with Cholecalciferol.Approved, Investigational
CephalexinThe metabolism of Cephalexin can be decreased when combined with Cholecalciferol.Approved, Vet Approved
CeritinibThe serum concentration of Cholecalciferol can be increased when it is combined with Ceritinib.Approved
CevimelineThe metabolism of Cevimeline can be decreased when combined with Cholecalciferol.Approved
ChloramphenicolThe metabolism of Chloramphenicol can be decreased when combined with Cholecalciferol.Approved, Vet Approved
ChlordiazepoxideThe metabolism of Chlordiazepoxide can be decreased when combined with Cholecalciferol.Approved, Illicit
ChloroquineThe metabolism of Chloroquine can be decreased when combined with Cholecalciferol.Approved, Vet Approved
ChlorothiazideChlorothiazide may increase the hypercalcemic activities of Cholecalciferol.Approved, Vet Approved
ChlorphenamineThe metabolism of Chlorphenamine can be decreased when combined with Cholecalciferol.Approved
ChlorpromazineThe metabolism of Chlorpromazine can be decreased when combined with Cholecalciferol.Approved, Vet Approved
ChlorpropamideThe metabolism of Chlorpropamide can be decreased when combined with Cholecalciferol.Approved
ChlorthalidoneChlorthalidone may increase the hypercalcemic activities of Cholecalciferol.Approved
ChlorzoxazoneThe metabolism of Chlorzoxazone can be decreased when combined with Cholecalciferol.Approved
CholestyramineThe serum concentration of Cholecalciferol can be decreased when it is combined with Cholestyramine.Approved
CilostazolThe serum concentration of Cilostazol can be increased when it is combined with Cholecalciferol.Approved
CinnarizineThe metabolism of Cinnarizine can be decreased when combined with Cholecalciferol.Approved
CisaprideThe metabolism of Cisapride can be decreased when combined with Cholecalciferol.Approved, Investigational, Withdrawn
CitalopramThe serum concentration of Citalopram can be increased when it is combined with Cholecalciferol.Approved
ClarithromycinThe metabolism of Cholecalciferol can be decreased when combined with Clarithromycin.Approved
ClemastineThe metabolism of Cholecalciferol can be decreased when combined with Clemastine.Approved
ClevidipineThe metabolism of Clevidipine can be decreased when combined with Cholecalciferol.Approved
ClobazamThe metabolism of Clobazam can be decreased when combined with Cholecalciferol.Approved, Illicit
clomethiazoleThe metabolism of clomethiazole can be decreased when combined with Cholecalciferol.Investigational
ClomipramineThe metabolism of Clomipramine can be decreased when combined with Cholecalciferol.Approved, Vet Approved
ClonidineThe metabolism of Clonidine can be decreased when combined with Cholecalciferol.Approved
ClopidogrelThe serum concentration of the active metabolites of Clopidogrel can be reduced when Clopidogrel is used in combination with Cholecalciferol resulting in a loss in efficacy.Approved, Nutraceutical
ClotiazepamThe metabolism of Clotiazepam can be decreased when combined with Cholecalciferol.Approved, Illicit
ClotrimazoleThe metabolism of Cholecalciferol can be decreased when combined with Clotrimazole.Approved, Vet Approved
ClozapineThe metabolism of Clozapine can be decreased when combined with Cholecalciferol.Approved
CobicistatThe metabolism of Cholecalciferol can be decreased when combined with Cobicistat.Approved
CodeineThe therapeutic efficacy of Codeine can be decreased when used in combination with Cholecalciferol.Approved, Illicit
ColesevelamThe serum concentration of Cholecalciferol can be decreased when it is combined with Colesevelam.Approved
ColestipolThe serum concentration of Cholecalciferol can be decreased when it is combined with Colestipol.Approved
ConivaptanThe serum concentration of Cholecalciferol can be increased when it is combined with Conivaptan.Approved, Investigational
CrizotinibThe metabolism of Cholecalciferol can be decreased when combined with Crizotinib.Approved
CyclobenzaprineThe metabolism of Cyclobenzaprine can be decreased when combined with Cholecalciferol.Approved
CyclophosphamideThe metabolism of Cyclophosphamide can be decreased when combined with Cholecalciferol.Approved, Investigational
CyclosporineThe metabolism of Cholecalciferol can be decreased when combined with Cyclosporine.Approved, Investigational, Vet Approved
DabrafenibThe serum concentration of Cholecalciferol can be decreased when it is combined with Dabrafenib.Approved
DanazolDanazol may increase the hypercalcemic activities of Cholecalciferol.Approved
DapagliflozinThe metabolism of Dapagliflozin can be decreased when combined with Cholecalciferol.Approved
DapsoneThe metabolism of Dapsone can be decreased when combined with Cholecalciferol.Approved, Investigational
DarifenacinThe metabolism of Darifenacin can be decreased when combined with Cholecalciferol.Approved, Investigational
DarunavirThe metabolism of Cholecalciferol can be decreased when combined with Darunavir.Approved
DasabuvirThe metabolism of Dasabuvir can be decreased when combined with Cholecalciferol.Approved
DasatinibThe serum concentration of Cholecalciferol can be increased when it is combined with Dasatinib.Approved, Investigational
DebrisoquinThe metabolism of Debrisoquin can be decreased when combined with Cholecalciferol.Approved
DeferasiroxThe serum concentration of Cholecalciferol can be decreased when it is combined with Deferasirox.Approved, Investigational
DelavirdineThe metabolism of Cholecalciferol can be decreased when combined with Delavirdine.Approved
DesipramineThe metabolism of Desipramine can be decreased when combined with Cholecalciferol.Approved
DeslanosideCholecalciferol may increase the arrhythmogenic activities of Deslanoside.Approved
DexamethasoneThe serum concentration of Cholecalciferol can be decreased when it is combined with Dexamethasone.Approved, Investigational, Vet Approved
DexfenfluramineThe metabolism of Dexfenfluramine can be decreased when combined with Cholecalciferol.Approved, Illicit, Withdrawn
DexmethylphenidateThe metabolism of Dexmethylphenidate can be decreased when combined with Cholecalciferol.Approved
DextroamphetamineThe metabolism of Dextroamphetamine can be decreased when combined with Cholecalciferol.Approved, Illicit
DextromethorphanThe metabolism of Dextromethorphan can be decreased when combined with Cholecalciferol.Approved
DiazepamThe metabolism of Diazepam can be decreased when combined with Cholecalciferol.Approved, Illicit, Vet Approved
DiclofenacThe metabolism of Diclofenac can be decreased when combined with Cholecalciferol.Approved, Vet Approved
DicoumarolThe metabolism of Dicoumarol can be decreased when combined with Cholecalciferol.Approved
DigitoxinCholecalciferol may increase the arrhythmogenic activities of Digitoxin.Approved
DigoxinCholecalciferol may increase the arrhythmogenic activities of Digoxin.Approved
DihydrocodeineThe metabolism of Dihydrocodeine can be decreased when combined with Cholecalciferol.Approved, Illicit
DihydroergotamineThe metabolism of Cholecalciferol can be decreased when combined with Dihydroergotamine.Approved
DihydrotachysterolThe risk or severity of adverse effects can be increased when Cholecalciferol is combined with Dihydrotachysterol.Approved
DiltiazemThe metabolism of Cholecalciferol can be decreased when combined with Diltiazem.Approved
DiphenhydramineThe metabolism of Diphenhydramine can be decreased when combined with Cholecalciferol.Approved
DolasetronThe metabolism of Dolasetron can be decreased when combined with Cholecalciferol.Approved
DomperidoneThe metabolism of Domperidone can be decreased when combined with Cholecalciferol.Approved, Investigational, Vet Approved
DonepezilThe metabolism of Donepezil can be decreased when combined with Cholecalciferol.Approved
DopamineThe metabolism of Dopamine can be decreased when combined with Cholecalciferol.Approved
DorzolamideThe metabolism of Dorzolamide can be decreased when combined with Cholecalciferol.Approved
DoxazosinThe metabolism of Doxazosin can be decreased when combined with Cholecalciferol.Approved
DoxepinThe metabolism of Doxepin can be decreased when combined with Cholecalciferol.Approved
DoxercalciferolThe risk or severity of adverse effects can be increased when Cholecalciferol is combined with Doxercalciferol.Approved
DoxorubicinThe serum concentration of Doxorubicin can be increased when it is combined with Cholecalciferol.Approved, Investigational
DoxorubicinThe metabolism of Doxorubicin can be decreased when combined with Cholecalciferol.Approved, Investigational
DoxycyclineThe metabolism of Cholecalciferol can be decreased when combined with Doxycycline.Approved, Investigational, Vet Approved
DronabinolThe serum concentration of Dronabinol can be increased when it is combined with Cholecalciferol.Approved, Illicit
DronedaroneThe metabolism of Cholecalciferol can be decreased when combined with Dronedarone.Approved
DuloxetineThe metabolism of Duloxetine can be decreased when combined with Cholecalciferol.Approved
EfavirenzThe serum concentration of Cholecalciferol can be decreased when it is combined with Efavirenz.Approved, Investigational
EletriptanThe metabolism of Eletriptan can be decreased when combined with Cholecalciferol.Approved, Investigational
EliglustatThe serum concentration of Eliglustat can be increased when it is combined with Cholecalciferol.Approved
EncainideThe metabolism of Encainide can be decreased when combined with Cholecalciferol.Approved, Withdrawn
EnclomipheneThe metabolism of Enclomiphene can be decreased when combined with Cholecalciferol.Investigational
EnfuvirtideThe metabolism of Enfuvirtide can be decreased when combined with Cholecalciferol.Approved, Investigational
EnzalutamideThe serum concentration of Cholecalciferol can be decreased when it is combined with Enzalutamide.Approved
EpinastineThe metabolism of Epinastine can be decreased when combined with Cholecalciferol.Approved, Investigational
EpoprostenolThe metabolism of Epoprostenol can be decreased when combined with Cholecalciferol.Approved
ErgocalciferolThe risk or severity of adverse effects can be increased when Ergocalciferol is combined with Cholecalciferol.Approved, Nutraceutical
ErlotinibThe metabolism of Erlotinib can be decreased when combined with Cholecalciferol.Approved, Investigational
ErythromycinThe metabolism of Cholecalciferol can be decreased when combined with Erythromycin.Approved, Vet Approved
EscitalopramThe metabolism of Escitalopram can be decreased when combined with Cholecalciferol.Approved, Investigational
Eslicarbazepine acetateThe serum concentration of Cholecalciferol can be decreased when it is combined with Eslicarbazepine acetate.Approved
EsmirtazapineThe metabolism of Esmirtazapine can be decreased when combined with Cholecalciferol.Investigational
EsomeprazoleThe metabolism of Esomeprazole can be decreased when combined with Cholecalciferol.Approved, Investigational
EstradiolThe metabolism of Estradiol can be decreased when combined with Cholecalciferol.Approved, Investigational, Vet Approved
EstroneThe metabolism of Estrone can be decreased when combined with Cholecalciferol.Approved
EszopicloneThe metabolism of Eszopiclone can be decreased when combined with Cholecalciferol.Approved
EthylmorphineThe metabolism of Ethylmorphine can be decreased when combined with Cholecalciferol.Approved, Illicit
EtodolacThe metabolism of Etodolac can be decreased when combined with Cholecalciferol.Approved, Investigational, Vet Approved
EtoricoxibThe metabolism of Etoricoxib can be decreased when combined with Cholecalciferol.Approved, Investigational
EtravirineThe serum concentration of Cholecalciferol can be decreased when it is combined with Etravirine.Approved
FamotidineThe metabolism of Famotidine can be decreased when combined with Cholecalciferol.Approved
FesoterodineThe serum concentration of the active metabolites of Fesoterodine can be increased when Fesoterodine is used in combination with Cholecalciferol.Approved
FingolimodThe metabolism of Fingolimod can be decreased when combined with Cholecalciferol.Approved, Investigational
FlecainideThe metabolism of Flecainide can be decreased when combined with Cholecalciferol.Approved, Withdrawn
FluconazoleThe metabolism of Cholecalciferol can be decreased when combined with Fluconazole.Approved
FlunarizineThe metabolism of Flunarizine can be decreased when combined with Cholecalciferol.Approved
FlunitrazepamThe metabolism of Flunitrazepam can be decreased when combined with Cholecalciferol.Approved, Illicit
FluoxetineThe metabolism of Fluoxetine can be decreased when combined with Cholecalciferol.Approved, Vet Approved
FluphenazineThe metabolism of Fluphenazine can be decreased when combined with Cholecalciferol.Approved
FlurbiprofenThe metabolism of Flurbiprofen can be decreased when combined with Cholecalciferol.Approved, Investigational
FlutamideThe metabolism of Flutamide can be decreased when combined with Cholecalciferol.Approved
FluvastatinThe metabolism of Fluvastatin can be decreased when combined with Cholecalciferol.Approved
FluvoxamineThe metabolism of Cholecalciferol can be decreased when combined with Fluvoxamine.Approved, Investigational
FormoterolThe metabolism of Formoterol can be decreased when combined with Cholecalciferol.Approved, Investigational
FosamprenavirThe metabolism of Cholecalciferol can be decreased when combined with Fosamprenavir.Approved
FosaprepitantThe serum concentration of Cholecalciferol can be increased when it is combined with Fosaprepitant.Approved
FosphenytoinThe metabolism of Cholecalciferol can be increased when combined with Fosphenytoin.Approved
Fusidic AcidThe serum concentration of Cholecalciferol can be increased when it is combined with Fusidic Acid.Approved
GalantamineThe metabolism of Galantamine can be decreased when combined with Cholecalciferol.Approved
GavestinelThe metabolism of Gavestinel can be decreased when combined with Cholecalciferol.Investigational
GefitinibThe metabolism of Gefitinib can be decreased when combined with Cholecalciferol.Approved, Investigational
GliclazideThe metabolism of Gliclazide can be decreased when combined with Cholecalciferol.Approved
GlimepirideThe metabolism of Glimepiride can be decreased when combined with Cholecalciferol.Approved
GlipizideThe metabolism of Glipizide can be decreased when combined with Cholecalciferol.Approved
GlucosamineThe metabolism of Glucosamine can be decreased when combined with Cholecalciferol.Approved
GlyburideThe metabolism of Glyburide can be decreased when combined with Cholecalciferol.Approved
GranisetronThe metabolism of Granisetron can be decreased when combined with Cholecalciferol.Approved, Investigational
GuanfacineThe metabolism of Guanfacine can be decreased when combined with Cholecalciferol.Approved, Investigational
HalofantrineThe metabolism of Halofantrine can be decreased when combined with Cholecalciferol.Approved
HaloperidolThe metabolism of Haloperidol can be decreased when combined with Cholecalciferol.Approved
HalothaneThe metabolism of Halothane can be decreased when combined with Cholecalciferol.Approved, Vet Approved
HexobarbitalThe metabolism of Hexobarbital can be decreased when combined with Cholecalciferol.Approved
Histamine PhosphateThe metabolism of Histamine Phosphate can be decreased when combined with Cholecalciferol.Approved
HydrochlorothiazideHydrochlorothiazide may increase the hypercalcemic activities of Cholecalciferol.Approved, Vet Approved
HydrocodoneThe metabolism of Hydrocodone can be decreased when combined with Cholecalciferol.Approved, Illicit
HydroflumethiazideHydroflumethiazide may increase the hypercalcemic activities of Cholecalciferol.Approved
HydromorphoneThe metabolism of Hydromorphone can be decreased when combined with Cholecalciferol.Approved, Illicit
IbrutinibThe metabolism of Ibrutinib can be decreased when combined with Cholecalciferol.Approved
IbuprofenThe metabolism of Ibuprofen can be decreased when combined with Cholecalciferol.Approved
IdarubicinThe metabolism of Idarubicin can be decreased when combined with Cholecalciferol.Approved
IdelalisibThe serum concentration of Cholecalciferol can be increased when it is combined with Idelalisib.Approved
IfosfamideThe metabolism of Ifosfamide can be decreased when combined with Cholecalciferol.Approved
IloperidoneThe metabolism of Iloperidone can be decreased when combined with Cholecalciferol.Approved
ImatinibThe metabolism of Cholecalciferol can be decreased when combined with Imatinib.Approved
ImipramineThe metabolism of Imipramine can be decreased when combined with Cholecalciferol.Approved
IndapamideIndapamide may increase the hypercalcemic activities of Cholecalciferol.Approved
IndinavirThe metabolism of Cholecalciferol can be decreased when combined with Indinavir.Approved
indisulamThe metabolism of indisulam can be decreased when combined with Cholecalciferol.Investigational
IndomethacinThe metabolism of Indomethacin can be decreased when combined with Cholecalciferol.Approved, Investigational
Ipratropium bromideThe metabolism of Ipratropium bromide can be decreased when combined with Cholecalciferol.Approved
IrbesartanThe metabolism of Irbesartan can be decreased when combined with Cholecalciferol.Approved, Investigational
IsavuconazoniumThe metabolism of Cholecalciferol can be decreased when combined with Isavuconazonium.Approved, Investigational
IsradipineThe metabolism of Cholecalciferol can be decreased when combined with Isradipine.Approved
ItraconazoleThe metabolism of Cholecalciferol can be decreased when combined with Itraconazole.Approved, Investigational
IvacaftorThe serum concentration of Cholecalciferol can be increased when it is combined with Ivacaftor.Approved
IxazomibThe metabolism of Ixazomib can be decreased when combined with Cholecalciferol.Approved
KetamineThe metabolism of Ketamine can be decreased when combined with Cholecalciferol.Approved, Vet Approved
KetobemidoneThe metabolism of Ketobemidone can be decreased when combined with Cholecalciferol.Approved
KetoconazoleThe metabolism of Cholecalciferol can be decreased when combined with Ketoconazole.Approved, Investigational
KetoprofenThe metabolism of Ketoprofen can be decreased when combined with Cholecalciferol.Approved, Vet Approved
LabetalolThe metabolism of Labetalol can be decreased when combined with Cholecalciferol.Approved
LansoprazoleThe metabolism of Lansoprazole can be decreased when combined with Cholecalciferol.Approved, Investigational
LapatinibThe metabolism of Lapatinib can be decreased when combined with Cholecalciferol.Approved, Investigational
LeflunomideThe metabolism of Leflunomide can be decreased when combined with Cholecalciferol.Approved, Investigational
LesinuradThe metabolism of Lesinurad can be decreased when combined with Cholecalciferol.Approved
LevodopaThe metabolism of Levodopa can be decreased when combined with Cholecalciferol.Approved
LevomilnacipranThe metabolism of Levomilnacipran can be decreased when combined with Cholecalciferol.Approved
LicofeloneThe metabolism of Licofelone can be decreased when combined with Cholecalciferol.Investigational
LidocaineThe metabolism of Lidocaine can be decreased when combined with Cholecalciferol.Approved, Vet Approved
LisurideThe metabolism of Lisuride can be decreased when combined with Cholecalciferol.Approved
LomustineThe metabolism of Lomustine can be decreased when combined with Cholecalciferol.Approved
LoperamideThe metabolism of Loperamide can be decreased when combined with Cholecalciferol.Approved
LopinavirThe metabolism of Cholecalciferol can be decreased when combined with Lopinavir.Approved
LoratadineThe metabolism of Loratadine can be decreased when combined with Cholecalciferol.Approved
LorcaserinThe metabolism of Lorcaserin can be decreased when combined with Cholecalciferol.Approved
LornoxicamThe metabolism of Lornoxicam can be decreased when combined with Cholecalciferol.Approved
LosartanThe metabolism of Losartan can be decreased when combined with Cholecalciferol.Approved
LovastatinThe metabolism of Cholecalciferol can be decreased when combined with Lovastatin.Approved, Investigational
LuliconazoleThe serum concentration of Cholecalciferol can be increased when it is combined with Luliconazole.Approved
LumacaftorThe metabolism of Cholecalciferol can be increased when combined with Lumacaftor.Approved
LumiracoxibThe metabolism of Lumiracoxib can be decreased when combined with Cholecalciferol.Approved, Investigational
MacitentanThe metabolism of Macitentan can be decreased when combined with Cholecalciferol.Approved
MaprotilineThe metabolism of Maprotiline can be decreased when combined with Cholecalciferol.Approved
Mefenamic acidThe metabolism of Mefenamic acid can be decreased when combined with Cholecalciferol.Approved
MelatoninThe metabolism of Melatonin can be decreased when combined with Cholecalciferol.Approved, Nutraceutical, Vet Approved
MeloxicamThe metabolism of Meloxicam can be decreased when combined with Cholecalciferol.Approved, Vet Approved
MephenytoinThe metabolism of Mephenytoin can be decreased when combined with Cholecalciferol.Investigational, Withdrawn
MeprobamateThe metabolism of Meprobamate can be decreased when combined with Cholecalciferol.Approved, Illicit
MequitazineThe metabolism of Mequitazine can be decreased when combined with Cholecalciferol.Approved
MesoridazineThe metabolism of Mesoridazine can be decreased when combined with Cholecalciferol.Approved
MestranolThe metabolism of Mestranol can be decreased when combined with Cholecalciferol.Approved
MethadoneThe metabolism of Methadone can be decreased when combined with Cholecalciferol.Approved
MethamphetamineThe metabolism of Methamphetamine can be decreased when combined with Cholecalciferol.Approved, Illicit
MethotrimeprazineThe metabolism of Methotrimeprazine can be decreased when combined with Cholecalciferol.Approved
MethoxyfluraneThe metabolism of Methoxyflurane can be decreased when combined with Cholecalciferol.Approved, Vet Approved
MethsuximideThe metabolism of Methsuximide can be decreased when combined with Cholecalciferol.Approved
MethyclothiazideMethyclothiazide may increase the hypercalcemic activities of Cholecalciferol.Approved
MethylphenidateThe metabolism of Methylphenidate can be decreased when combined with Cholecalciferol.Approved, Investigational
MethylphenobarbitalThe metabolism of Methylphenobarbital can be decreased when combined with Cholecalciferol.Approved
MethyprylonThe metabolism of Methyprylon can be decreased when combined with Cholecalciferol.Approved, Illicit, Withdrawn
MetoclopramideThe metabolism of Metoclopramide can be decreased when combined with Cholecalciferol.Approved, Investigational
MetolazoneMetolazone may increase the hypercalcemic activities of Cholecalciferol.Approved
MetoprololThe serum concentration of Metoprolol can be increased when it is combined with Cholecalciferol.Approved, Investigational
MetronidazoleThe metabolism of Metronidazole can be decreased when combined with Cholecalciferol.Approved
MexiletineThe metabolism of Mexiletine can be decreased when combined with Cholecalciferol.Approved
MianserinThe metabolism of Mianserin can be decreased when combined with Cholecalciferol.Approved
MifepristoneThe serum concentration of Cholecalciferol can be increased when it is combined with Mifepristone.Approved, Investigational
MinaprineThe metabolism of Minaprine can be decreased when combined with Cholecalciferol.Approved
Mineral oilThe serum concentration of Cholecalciferol can be decreased when it is combined with Mineral oil.Approved
MirabegronThe metabolism of Mirabegron can be decreased when combined with Cholecalciferol.Approved
MirtazapineThe metabolism of Mirtazapine can be decreased when combined with Cholecalciferol.Approved
MitotaneThe serum concentration of Cholecalciferol can be decreased when it is combined with Mitotane.Approved
MoclobemideThe metabolism of Moclobemide can be decreased when combined with Cholecalciferol.Approved
ModafinilThe serum concentration of Cholecalciferol can be decreased when it is combined with Modafinil.Approved, Investigational
MontelukastThe metabolism of Montelukast can be decreased when combined with Cholecalciferol.Approved
MorphineThe metabolism of Morphine can be decreased when combined with Cholecalciferol.Approved, Investigational
NafcillinThe serum concentration of Cholecalciferol can be decreased when it is combined with Nafcillin.Approved
NaproxenThe metabolism of Naproxen can be decreased when combined with Cholecalciferol.Approved, Vet Approved
NateglinideThe metabolism of Nateglinide can be decreased when combined with Cholecalciferol.Approved, Investigational
NebivololThe serum concentration of Nebivolol can be increased when it is combined with Cholecalciferol.Approved, Investigational
NefazodoneThe metabolism of Cholecalciferol can be decreased when combined with Nefazodone.Approved, Withdrawn
NelfinavirThe metabolism of Cholecalciferol can be decreased when combined with Nelfinavir.Approved
NetupitantThe serum concentration of Cholecalciferol can be increased when it is combined with Netupitant.Approved
NevirapineThe metabolism of Cholecalciferol can be increased when combined with Nevirapine.Approved
NicardipineThe metabolism of Nicardipine can be decreased when combined with Cholecalciferol.Approved
NicergolineThe metabolism of Nicergoline can be decreased when combined with Cholecalciferol.Approved
NiclosamideThe metabolism of Niclosamide can be decreased when combined with Cholecalciferol.Approved, Vet Approved
NicotineThe metabolism of Nicotine can be decreased when combined with Cholecalciferol.Approved
NifedipineThe metabolism of Nifedipine can be decreased when combined with Cholecalciferol.Approved
NilotinibThe metabolism of Cholecalciferol can be decreased when combined with Nilotinib.Approved, Investigational
NilutamideThe metabolism of Nilutamide can be decreased when combined with Cholecalciferol.Approved
NitrofuralThe metabolism of Nitrofural can be decreased when combined with Cholecalciferol.Approved, Vet Approved
NortriptylineThe metabolism of Nortriptyline can be decreased when combined with Cholecalciferol.Approved
OlanzapineThe metabolism of Olanzapine can be decreased when combined with Cholecalciferol.Approved, Investigational
OlaparibThe metabolism of Cholecalciferol can be decreased when combined with Olaparib.Approved
OlodaterolThe metabolism of Olodaterol can be decreased when combined with Cholecalciferol.Approved
OmeprazoleThe metabolism of Omeprazole can be decreased when combined with Cholecalciferol.Approved, Investigational, Vet Approved
OndansetronThe metabolism of Ondansetron can be decreased when combined with Cholecalciferol.Approved
OrlistatThe serum concentration of Cholecalciferol can be decreased when it is combined with Orlistat.Approved, Investigational
OsimertinibThe serum concentration of Cholecalciferol can be increased when it is combined with Osimertinib.Approved
OspemifeneThe metabolism of Ospemifene can be decreased when combined with Cholecalciferol.Approved
OuabainCholecalciferol may increase the arrhythmogenic activities of Ouabain.Approved
OxaprozinThe metabolism of Oxaprozin can be decreased when combined with Cholecalciferol.Approved
OxiconazoleThe metabolism of Oxiconazole can be decreased when combined with Cholecalciferol.Approved
OxycodoneThe metabolism of Oxycodone can be decreased when combined with Cholecalciferol.Approved, Illicit, Investigational
OxymorphoneThe metabolism of Oxymorphone can be decreased when combined with Cholecalciferol.Approved, Investigational, Vet Approved
PaclitaxelThe metabolism of Paclitaxel can be decreased when combined with Cholecalciferol.Approved, Vet Approved
PalbociclibThe serum concentration of Cholecalciferol can be increased when it is combined with Palbociclib.Approved
PalonosetronThe metabolism of Palonosetron can be decreased when combined with Cholecalciferol.Approved, Investigational
PantoprazoleThe metabolism of Pantoprazole can be decreased when combined with Cholecalciferol.Approved
ParamethadioneThe metabolism of Paramethadione can be decreased when combined with Cholecalciferol.Approved
ParecoxibThe metabolism of Parecoxib can be decreased when combined with Cholecalciferol.Approved
ParicalcitolThe risk or severity of adverse effects can be increased when Cholecalciferol is combined with Paricalcitol.Approved, Investigational
ParoxetineThe metabolism of Paroxetine can be decreased when combined with Cholecalciferol.Approved, Investigational
PazopanibThe metabolism of Pazopanib can be decreased when combined with Cholecalciferol.Approved
PentamidineThe metabolism of Pentamidine can be decreased when combined with Cholecalciferol.Approved
PentobarbitalThe metabolism of Cholecalciferol can be increased when combined with Pentobarbital.Approved, Vet Approved
PerhexilineThe metabolism of Perhexiline can be decreased when combined with Cholecalciferol.Approved
PerphenazineThe metabolism of Perphenazine can be decreased when combined with Cholecalciferol.Approved
PethidineThe metabolism of Pethidine can be decreased when combined with Cholecalciferol.Approved
PhenacetinThe metabolism of Phenacetin can be decreased when combined with Cholecalciferol.Withdrawn
PhenforminThe metabolism of Phenformin can be decreased when combined with Cholecalciferol.Approved, Withdrawn
PhenobarbitalThe metabolism of Cholecalciferol can be increased when combined with Phenobarbital.Approved
PhenprocoumonThe metabolism of Phenprocoumon can be decreased when combined with Cholecalciferol.Approved
PhenylbutazoneThe metabolism of Phenylbutazone can be decreased when combined with Cholecalciferol.Approved, Vet Approved
PhenytoinThe metabolism of Cholecalciferol can be increased when combined with Phenytoin.Approved, Vet Approved
PindololThe metabolism of Pindolol can be decreased when combined with Cholecalciferol.Approved
PioglitazoneThe metabolism of Pioglitazone can be decreased when combined with Cholecalciferol.Approved, Investigational
PiperazineThe metabolism of Piperazine can be decreased when combined with Cholecalciferol.Approved, Vet Approved
PipotiazineThe metabolism of Pipotiazine can be decreased when combined with Cholecalciferol.Approved
PiroxicamThe metabolism of Piroxicam can be decreased when combined with Cholecalciferol.Approved, Investigational
PitavastatinThe metabolism of Pitavastatin can be decreased when combined with Cholecalciferol.Approved
PodofiloxThe metabolism of Podofilox can be decreased when combined with Cholecalciferol.Approved
PolythiazidePolythiazide may increase the hypercalcemic activities of Cholecalciferol.Approved
PonatinibThe metabolism of Ponatinib can be decreased when combined with Cholecalciferol.Approved
PosaconazoleThe metabolism of Cholecalciferol can be decreased when combined with Posaconazole.Approved, Investigational, Vet Approved
PrasugrelThe metabolism of Prasugrel can be decreased when combined with Cholecalciferol.Approved
PravastatinThe metabolism of Pravastatin can be decreased when combined with Cholecalciferol.Approved
PraziquantelThe metabolism of Praziquantel can be decreased when combined with Cholecalciferol.Approved, Vet Approved
PrimidoneThe metabolism of Cholecalciferol can be increased when combined with Primidone.Approved, Vet Approved
ProcainamideThe metabolism of Procainamide can be decreased when combined with Cholecalciferol.Approved
ProchlorperazineThe metabolism of Prochlorperazine can be decreased when combined with Cholecalciferol.Approved, Vet Approved
ProgesteroneThe metabolism of Progesterone can be decreased when combined with Cholecalciferol.Approved, Vet Approved
ProguanilThe metabolism of Proguanil can be decreased when combined with Cholecalciferol.Approved
PromazineThe metabolism of Promazine can be decreased when combined with Cholecalciferol.Approved, Vet Approved
PromethazineThe metabolism of Promethazine can be decreased when combined with Cholecalciferol.Approved
PropafenoneThe serum concentration of Cholecalciferol can be increased when it is combined with Propafenone.Approved
PropofolThe metabolism of Propofol can be decreased when combined with Cholecalciferol.Approved, Investigational, Vet Approved
PropranololThe metabolism of Propranolol can be decreased when combined with Cholecalciferol.Approved, Investigational
ProtriptylineThe metabolism of Protriptyline can be decreased when combined with Cholecalciferol.Approved
PseudoephedrineThe metabolism of Pseudoephedrine can be decreased when combined with Cholecalciferol.Approved
QuazepamThe metabolism of Quazepam can be decreased when combined with Cholecalciferol.Approved, Illicit
QuetiapineThe metabolism of Quetiapine can be decreased when combined with Cholecalciferol.Approved
QuinethazoneQuinethazone may increase the hypercalcemic activities of Cholecalciferol.Approved
QuinidineThe metabolism of Quinidine can be decreased when combined with Cholecalciferol.Approved
QuinineThe metabolism of Quinine can be decreased when combined with Cholecalciferol.Approved
RabeprazoleThe metabolism of Rabeprazole can be decreased when combined with Cholecalciferol.Approved, Investigational
RamelteonThe metabolism of Ramelteon can be decreased when combined with Cholecalciferol.Approved, Investigational
RanitidineThe metabolism of Ranitidine can be decreased when combined with Cholecalciferol.Approved
RanolazineThe metabolism of Cholecalciferol can be decreased when combined with Ranolazine.Approved, Investigational
RemoxiprideThe metabolism of Remoxipride can be decreased when combined with Cholecalciferol.Approved, Withdrawn
repinotanThe metabolism of repinotan can be decreased when combined with Cholecalciferol.Investigational
RifabutinThe metabolism of Cholecalciferol can be increased when combined with Rifabutin.Approved
RifampicinThe metabolism of Cholecalciferol can be increased when combined with Rifampicin.Approved
RifapentineThe metabolism of Cholecalciferol can be increased when combined with Rifapentine.Approved
RisperidoneThe metabolism of Risperidone can be decreased when combined with Cholecalciferol.Approved, Investigational
RitonavirThe metabolism of Cholecalciferol can be decreased when combined with Ritonavir.Approved, Investigational
RofecoxibThe metabolism of Rofecoxib can be decreased when combined with Cholecalciferol.Investigational, Withdrawn
RomidepsinThe metabolism of Romidepsin can be decreased when combined with Cholecalciferol.Approved, Investigational
RopivacaineThe metabolism of Ropivacaine can be decreased when combined with Cholecalciferol.Approved
RosiglitazoneThe metabolism of Rosiglitazone can be decreased when combined with Cholecalciferol.Approved, Investigational
RosuvastatinThe metabolism of Rosuvastatin can be decreased when combined with Cholecalciferol.Approved
RotigotineThe metabolism of Rotigotine can be decreased when combined with Cholecalciferol.Approved
Salicylic acidThe metabolism of Salicylic acid can be decreased when combined with Cholecalciferol.Approved, Vet Approved
SaquinavirThe metabolism of Cholecalciferol can be decreased when combined with Saquinavir.Approved, Investigational
SelegilineThe metabolism of Selegiline can be decreased when combined with Cholecalciferol.Approved, Investigational, Vet Approved
SeratrodastThe metabolism of Seratrodast can be decreased when combined with Cholecalciferol.Approved, Investigational
SertindoleThe metabolism of Sertindole can be decreased when combined with Cholecalciferol.Approved, Withdrawn
SertralineThe metabolism of Sertraline can be decreased when combined with Cholecalciferol.Approved
SildenafilThe metabolism of Cholecalciferol can be decreased when combined with Sildenafil.Approved, Investigational
SiltuximabThe serum concentration of Cholecalciferol can be decreased when it is combined with Siltuximab.Approved
SimeprevirThe serum concentration of Cholecalciferol can be increased when it is combined with Simeprevir.Approved
SimvastatinThe metabolism of Simvastatin can be decreased when combined with Cholecalciferol.Approved
SitaxentanThe metabolism of Sitaxentan can be decreased when combined with Cholecalciferol.Approved, Investigational, Withdrawn
SparteineThe metabolism of Sparteine can be decreased when combined with Cholecalciferol.Experimental
St. John's WortThe serum concentration of Cholecalciferol can be decreased when it is combined with St. John's Wort.Nutraceutical
StiripentolThe serum concentration of Cholecalciferol can be increased when it is combined with Stiripentol.Approved
SucralfateThe serum concentration of Sucralfate can be increased when it is combined with Cholecalciferol.Approved
SulfadiazineThe metabolism of Sulfadiazine can be decreased when combined with Cholecalciferol.Approved, Vet Approved
SulfamethoxazoleThe metabolism of Sulfamethoxazole can be decreased when combined with Cholecalciferol.Approved
SulfamoxoleThe metabolism of Sulfamoxole can be decreased when combined with Cholecalciferol.Approved
SulfinpyrazoneThe metabolism of Sulfinpyrazone can be decreased when combined with Cholecalciferol.Approved
SulfisoxazoleThe metabolism of Cholecalciferol can be decreased when combined with Sulfisoxazole.Approved, Vet Approved
SuprofenThe metabolism of Suprofen can be decreased when combined with Cholecalciferol.Approved, Withdrawn
TamoxifenThe serum concentration of the active metabolites of Tamoxifen can be reduced when Tamoxifen is used in combination with Cholecalciferol resulting in a loss in efficacy.Approved
TamsulosinThe metabolism of Tamsulosin can be decreased when combined with Cholecalciferol.Approved, Investigational
TapentadolThe metabolism of Tapentadol can be decreased when combined with Cholecalciferol.Approved
TegaserodThe metabolism of Tegaserod can be decreased when combined with Cholecalciferol.Investigational, Withdrawn
TelaprevirThe metabolism of Cholecalciferol can be decreased when combined with Telaprevir.Approved
TelithromycinThe metabolism of Cholecalciferol can be decreased when combined with Telithromycin.Approved
TemazepamThe metabolism of Temazepam can be decreased when combined with Cholecalciferol.Approved
TeniposideThe metabolism of Teniposide can be decreased when combined with Cholecalciferol.Approved
TenoxicamThe metabolism of Tenoxicam can be decreased when combined with Cholecalciferol.Approved
TerbinafineThe metabolism of Terbinafine can be decreased when combined with Cholecalciferol.Approved, Investigational, Vet Approved
TerfenadineThe metabolism of Terfenadine can be decreased when combined with Cholecalciferol.Withdrawn
TesmilifeneThe metabolism of Tesmilifene can be decreased when combined with Cholecalciferol.Investigational
TestosteroneThe metabolism of Testosterone can be decreased when combined with Cholecalciferol.Approved, Investigational
TetrabenazineThe metabolism of Tetrabenazine can be decreased when combined with Cholecalciferol.Approved
ThalidomideThe metabolism of Thalidomide can be decreased when combined with Cholecalciferol.Approved, Investigational, Withdrawn
TheophyllineThe metabolism of Theophylline can be decreased when combined with Cholecalciferol.Approved
ThiamylalThe metabolism of Thiamylal can be decreased when combined with Cholecalciferol.Approved, Vet Approved
ThioridazineThe serum concentration of Thioridazine can be increased when it is combined with Cholecalciferol.Approved
TiclopidineThe metabolism of Cholecalciferol can be decreased when combined with Ticlopidine.Approved
TimololThe metabolism of Timolol can be decreased when combined with Cholecalciferol.Approved
TiotropiumThe metabolism of Tiotropium can be decreased when combined with Cholecalciferol.Approved
TipranavirThe metabolism of Tipranavir can be decreased when combined with Cholecalciferol.Approved, Investigational
TocilizumabThe serum concentration of Cholecalciferol can be decreased when it is combined with Tocilizumab.Approved
TofacitinibThe metabolism of Tofacitinib can be decreased when combined with Cholecalciferol.Approved, Investigational
TolbutamideThe metabolism of Tolbutamide can be decreased when combined with Cholecalciferol.Approved
TolterodineThe metabolism of Tolterodine can be decreased when combined with Cholecalciferol.Approved, Investigational
TorasemideThe metabolism of Torasemide can be decreased when combined with Cholecalciferol.Approved
TrabectedinThe metabolism of Trabectedin can be decreased when combined with Cholecalciferol.Approved, Investigational
TramadolThe therapeutic efficacy of Tramadol can be decreased when used in combination with Cholecalciferol.Approved, Investigational
TrazodoneThe metabolism of Trazodone can be decreased when combined with Cholecalciferol.Approved, Investigational
TreprostinilThe metabolism of Treprostinil can be decreased when combined with Cholecalciferol.Approved, Investigational
TretinoinThe metabolism of Tretinoin can be decreased when combined with Cholecalciferol.Approved, Investigational, Nutraceutical
TrichlormethiazideTrichlormethiazide may increase the hypercalcemic activities of Cholecalciferol.Approved, Vet Approved
TrimethadioneThe metabolism of Trimethadione can be decreased when combined with Cholecalciferol.Approved
TrimethoprimThe metabolism of Trimethoprim can be decreased when combined with Cholecalciferol.Approved, Vet Approved
TrimipramineThe metabolism of Trimipramine can be decreased when combined with Cholecalciferol.Approved
TroglitazoneThe metabolism of Troglitazone can be decreased when combined with Cholecalciferol.Withdrawn
UmeclidiniumThe metabolism of Umeclidinium can be decreased when combined with Cholecalciferol.Approved
ValdecoxibThe metabolism of Valdecoxib can be decreased when combined with Cholecalciferol.Investigational, Withdrawn
Valproic AcidThe metabolism of Valproic Acid can be decreased when combined with Cholecalciferol.Approved, Investigational
ValsartanThe metabolism of Valsartan can be decreased when combined with Cholecalciferol.Approved, Investigational
VenlafaxineThe metabolism of Cholecalciferol can be decreased when combined with Venlafaxine.Approved
VerapamilThe metabolism of Cholecalciferol can be decreased when combined with Verapamil.Approved
VicrivirocThe metabolism of Vicriviroc can be decreased when combined with Cholecalciferol.Investigational
VilazodoneThe metabolism of Vilazodone can be decreased when combined with Cholecalciferol.Approved
VinblastineThe metabolism of Vinblastine can be decreased when combined with Cholecalciferol.Approved
VinorelbineThe metabolism of Vinorelbine can be decreased when combined with Cholecalciferol.Approved, Investigational
VismodegibThe metabolism of Vismodegib can be decreased when combined with Cholecalciferol.Approved
VoriconazoleThe metabolism of Cholecalciferol can be decreased when combined with Voriconazole.Approved, Investigational
VortioxetineThe metabolism of Vortioxetine can be decreased when combined with Cholecalciferol.Approved
WarfarinThe metabolism of Warfarin can be decreased when combined with Cholecalciferol.Approved
XimelagatranThe metabolism of Ximelagatran can be decreased when combined with Cholecalciferol.Approved, Investigational, Withdrawn
YohimbineThe metabolism of Yohimbine can be decreased when combined with Cholecalciferol.Approved, Vet Approved
ZafirlukastThe metabolism of Zafirlukast can be decreased when combined with Cholecalciferol.Approved, Investigational
ZalcitabineThe metabolism of Zalcitabine can be decreased when combined with Cholecalciferol.Approved
ZaltoprofenThe metabolism of Zaltoprofen can be decreased when combined with Cholecalciferol.Approved
ZidovudineThe metabolism of Zidovudine can be decreased when combined with Cholecalciferol.Approved
ZileutonThe metabolism of Zileuton can be decreased when combined with Cholecalciferol.Approved, Investigational, Withdrawn
ZiprasidoneThe metabolism of Cholecalciferol can be decreased when combined with Ziprasidone.Approved
ZolpidemThe metabolism of Zolpidem can be decreased when combined with Cholecalciferol.Approved
ZopicloneThe metabolism of Zopiclone can be decreased when combined with Cholecalciferol.Approved
ZuclopenthixolThe metabolism of Zuclopenthixol can be decreased when combined with Cholecalciferol.Approved, Investigational
Food InteractionsNot Available
References
Synthesis Reference

Jean Jolly, Primo Rizzi, Jean Taillardat, “1.alpha.,25.alpha.-Dihydroxy-cholecalciferol and methods for the production thereof.” U.S. Patent US4435325, issued May, 1977.

US4435325
General References
  1. Armas LA, Hollis BW, Heaney RP: Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab. 2004 Nov;89(11):5387-91. [PubMed:15531486 ]
External Links
ATC CodesM05BB08M05BB04A11CC05M05BB05M05BB03M05BX53M05BB07
AHFS Codes
  • 88:16.00
PDB EntriesNot Available
FDA labelNot Available
MSDSDownload (123 KB)
ADMET
Predicted ADMET features
PropertyValueProbability
Human Intestinal Absorption+1.0
Blood Brain Barrier+0.959
Caco-2 permeable+0.8342
P-glycoprotein substrateSubstrate0.6706
P-glycoprotein inhibitor IInhibitor0.7603
P-glycoprotein inhibitor IINon-inhibitor0.5346
Renal organic cation transporterNon-inhibitor0.7818
CYP450 2C9 substrateNon-substrate0.8384
CYP450 2D6 substrateNon-substrate0.9116
CYP450 3A4 substrateSubstrate0.7302
CYP450 1A2 substrateNon-inhibitor0.9256
CYP450 2C9 inhibitorNon-inhibitor0.9071
CYP450 2D6 inhibitorNon-inhibitor0.9551
CYP450 2C19 inhibitorNon-inhibitor0.9026
CYP450 3A4 inhibitorNon-inhibitor0.7881
CYP450 inhibitory promiscuityLow CYP Inhibitory Promiscuity0.7093
Ames testNon AMES toxic0.9132
CarcinogenicityNon-carcinogens0.921
BiodegradationNot ready biodegradable0.9878
Rat acute toxicity3.9310 LD50, mol/kg Not applicable
hERG inhibition (predictor I)Weak inhibitor0.773
hERG inhibition (predictor II)Non-inhibitor0.7589
ADMET data is predicted using admetSAR, a free tool for evaluating chemical ADMET properties. (23092397 )
Pharmacoeconomics
ManufacturersNot Available
Packagers
Dosage forms
FormRouteStrength
OintmentTopical
Granule, effervescent; kit; tabletOral
CreamTopical
WaferOral
Solution / dropsOral400 unit
LiquidOral
WaferOral100 unit
TabletOral
PowderOral
Solution / dropsOral
SolutionOral
Tablet, chewableOral
CapsuleOral
Tablet, film coatedOral
CapsuleOral10000 unit
CapsuleOral5000 unit
CapsuleOral50000 unit
Tablet, coatedOral
Capsule, liquid filledOral
Tablet, effervescentOral
Capsule, gelatin coatedOral
Kit
TabletOral1000 unit
TabletOral400 unit
CapsuleOral100000 unit
CapsuleOral2000 unit
CapsuleOral25000 unit
Prices
Unit descriptionCostUnit
Cholecalciferol crystals104.3USD g
Vitamin d3 2400 unit/ml liquid0.8USD ml
Vitamin d3 2000 unit spray0.44USD ml
Vitamin d3 3000 unit tablet0.11USD tablet
Vitamin d-3 2000 unit tablet0.07USD tablet
CVS Pharmacy vitamin d 1000 unit tablet0.04USD tablet
Delta d3 400 unit tablet0.04USD each
Vitamin d 1000 unit tablet0.03USD tablet
Pv vitamin d 2000 unit tablet0.02USD tablet
Pv vitamin d 5000 unit tablet0.02USD tablet
Vitamin d 400 unit tablet0.02USD tablet
DrugBank does not sell nor buy drugs. Pricing information is supplied for informational purposes only.
Patents
Patent NumberPediatric ExtensionApprovedExpires (estimated)
US5994329 Yes1999-01-172019-01-17Us
Properties
StateSolid
Experimental Properties
PropertyValueSource
melting point84.5 °CPhysProp
water solubilityInsolubleNot Available
logP7.5Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.00038 mg/mLALOGPS
logP7.98ALOGPS
logP7.13ChemAxon
logS-6ALOGPS
pKa (Strongest Acidic)18.38ChemAxon
pKa (Strongest Basic)-1.3ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count1ChemAxon
Hydrogen Donor Count1ChemAxon
Polar Surface Area20.23 Å2ChemAxon
Rotatable Bond Count6ChemAxon
Refractivity123.22 m3·mol-1ChemAxon
Polarizability49.6 Å3ChemAxon
Number of Rings3ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleYesChemAxon
MDDR-like RuleYesChemAxon
Spectra
Mass Spec (NIST)Download (11.1 KB)
Spectra
Spectrum TypeDescriptionSplash Key
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, PositiveNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, PositiveNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, PositiveNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 10V, NegativeNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 20V, NegativeNot Available
Predicted LC-MS/MSPredicted LC-MS/MS Spectrum - 40V, NegativeNot Available
Taxonomy
DescriptionThis compound belongs to the class of organic compounds known as triterpenoids. These are terpene molecules containing 8 isoprene units.
KingdomOrganic compounds
Super ClassLipids and lipid-like molecules
ClassPrenol lipids
Sub ClassTriterpenoids
Direct ParentTriterpenoids
Alternative Parents
Substituents
  • Polycyclic triterpenoid
  • Triterpenoid
  • Steroid
  • Cyclohexanol
  • Cyclic alcohol
  • Secondary alcohol
  • Hydrocarbon derivative
  • Organooxygen compound
  • Alcohol
  • Aliphatic homopolycyclic compound
Molecular FrameworkAliphatic homopolycyclic compounds
External Descriptors

Targets

Kind
Protein
Organism
Human
Pharmacological action
yes
Actions
agonist
General Function:
Zinc ion binding
Specific Function:
Nuclear hormone receptor. Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes. Recruited to promoters via its interaction with BAZ1B/WSTF which mediates the interaction with acetylated histones, an essential step for VDR-promoter association. Plays a central role in calcium homeostasis.
Gene Name:
VDR
Uniprot ID:
P11473
Molecular Weight:
48288.64 Da
References
  1. Reinhart GA: Vitamin D analogs: novel therapeutic agents for cardiovascular disease? Curr Opin Investig Drugs. 2004 Sep;5(9):947-51. [PubMed:15503649 ]
  2. Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5. [PubMed:11752352 ]
  3. Fujishima T, Tsuji G, Tanaka C, Harayama H: Novel vitamin D receptor ligands having a carboxyl group as an anchor to arginine 274 in the ligand-binding domain. J Steroid Biochem Mol Biol. 2010 Jul;121(1-2):60-2. doi: 10.1016/j.jsbmb.2010.04.020. Epub 2010 May 6. [PubMed:20435140 ]

Enzymes

Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
substrate
General Function:
Vitamin d3 25-hydroxylase activity
Specific Function:
Has a D-25-hydroxylase activity on both forms of vitamin D, vitamin D(2) and D(3).
Gene Name:
CYP2R1
Uniprot ID:
Q6VVX0
Molecular Weight:
57358.82 Da
References
  1. Flanagan JN, Young MV, Persons KS, Wang L, Mathieu JS, Whitlatch LW, Holick MF, Chen TC: Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin D. Anticancer Res. 2006 Jul-Aug;26(4A):2567-72. [PubMed:16886665 ]
  2. Segura-Aguilar J: Peroxidase activity of liver microsomal vitamin D 25-hydroxylase and cytochrome P450 1A2 catalyzes 25-hydroxylation of vitamin D3 and oxidation of dopamine to aminochrome. Biochem Mol Med. 1996 Jun;58(1):122-9. [PubMed:8809353 ]
  3. Schuster I: Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta. 2011 Jan;1814(1):186-99. doi: 10.1016/j.bbapap.2010.06.022. Epub 2010 Jul 7. [PubMed:20619365 ]
  4. Ohyama Y, Yamasaki T: Eight cytochrome P450s catalyze vitamin D metabolism. Front Biosci. 2004 Sep 1;9:3007-18. [PubMed:15353333 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
substrate
General Function:
Vitamin d3 25-hydroxylase activity
Specific Function:
Catalyzes the first step in the oxidation of the side chain of sterol intermediates; the 27-hydroxylation of 5-beta-cholestane-3-alpha,7-alpha,12-alpha-triol. Has also a vitamin D3-25-hydroxylase activity.
Gene Name:
CYP27A1
Uniprot ID:
Q02318
Molecular Weight:
60234.28 Da
References
  1. Lehmann B, Tiebel O, Meurer M: Expression of vitamin D3 25-hydroxylase (CYP27) mRNA after induction by vitamin D3 or UVB radiation in keratinocytes of human skin equivalents--a preliminary study. Arch Dermatol Res. 1999 Sep;291(9):507-10. [PubMed:10541881 ]
  2. Sawada N, Sakaki T, Yoneda S, Kusudo T, Shinkyo R, Ohta M, Inouye K: Conversion of vitamin D3 to 1alpha,25-dihydroxyvitamin D3 by Streptomyces griseolus cytochrome P450SU-1. Biochem Biophys Res Commun. 2004 Jul 16;320(1):156-64. [PubMed:15207715 ]
  3. Uchida E, Kagawa N, Sakaki T, Urushino N, Sawada N, Kamakura M, Ohta M, Kato S, Inouye K: Purification and characterization of mouse CYP27B1 overproduced by an Escherichia coli system coexpressing molecular chaperonins GroEL/ES. Biochem Biophys Res Commun. 2004 Oct 15;323(2):505-11. [PubMed:15369780 ]
  4. Sakaki T, Kagawa N, Yamamoto K, Inouye K: Metabolism of vitamin D3 by cytochromes P450. Front Biosci. 2005 Jan 1;10:119-34. Print 2005 Jan 1. [PubMed:15574355 ]
  5. Tokar EJ, Webber MM: Cholecalciferol (vitamin D3) inhibits growth and invasion by up-regulating nuclear receptors and 25-hydroxylase (CYP27A1) in human prostate cancer cells. Clin Exp Metastasis. 2005;22(3):275-84. [PubMed:16158255 ]
  6. Schuster I: Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta. 2011 Jan;1814(1):186-99. doi: 10.1016/j.bbapap.2010.06.022. Epub 2010 Jul 7. [PubMed:20619365 ]
  7. Ohyama Y, Yamasaki T: Eight cytochrome P450s catalyze vitamin D metabolism. Front Biosci. 2004 Sep 1;9:3007-18. [PubMed:15353333 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
substrate
General Function:
Steroid hydroxylase activity
Specific Function:
This enzyme metabolizes arachidonic acid predominantly via a NADPH-dependent olefin epoxidation to all four regioisomeric cis-epoxyeicosatrienoic acids. One of the predominant enzymes responsible for the epoxidation of endogenous cardiac arachidonic acid pools.
Gene Name:
CYP2J2
Uniprot ID:
P51589
Molecular Weight:
57610.165 Da
References
  1. Aiba I, Yamasaki T, Shinki T, Izumi S, Yamamoto K, Yamada S, Terato H, Ide H, Ohyama Y: Characterization of rat and human CYP2J enzymes as Vitamin D 25-hydroxylases. Steroids. 2006 Oct;71(10):849-56. Epub 2006 Jul 13. [PubMed:16842832 ]
  2. Schuster I: Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta. 2011 Jan;1814(1):186-99. doi: 10.1016/j.bbapap.2010.06.022. Epub 2010 Jul 7. [PubMed:20619365 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
substrate
General Function:
Vitamin d3 25-hydroxylase activity
Specific Function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiot...
Gene Name:
CYP3A4
Uniprot ID:
P08684
Molecular Weight:
57342.67 Da
References
  1. Schuster I: Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta. 2011 Jan;1814(1):186-99. doi: 10.1016/j.bbapap.2010.06.022. Epub 2010 Jul 7. [PubMed:20619365 ]
  2. Ohyama Y, Yamasaki T: Eight cytochrome P450s catalyze vitamin D metabolism. Front Biosci. 2004 Sep 1;9:3007-18. [PubMed:15353333 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
substrate
General Function:
Oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, nad(p)h as one donor, and incorporation of one atom of oxygen
Specific Function:
Catalyzes the side-chain cleavage reaction of cholesterol to pregnenolone.
Gene Name:
CYP11A1
Uniprot ID:
P05108
Molecular Weight:
60101.87 Da
References
  1. Tuckey RC, Janjetovic Z, Li W, Nguyen MN, Zmijewski MA, Zjawiony J, Slominski A: Metabolism of 1alpha-hydroxyvitamin D3 by cytochrome P450scc to biologically active 1alpha,20-dihydroxyvitamin D3. J Steroid Biochem Mol Biol. 2008 Dec;112(4-5):213-9. doi: 10.1016/j.jsbmb.2008.10.005. Epub 2008 Oct 21. [PubMed:19000766 ]
  2. Tuckey RC, Nguyen MN, Slominski A: Kinetics of vitamin D3 metabolism by cytochrome P450scc (CYP11A1) in phospholipid vesicles and cyclodextrin. Int J Biochem Cell Biol. 2008;40(11):2619-26. doi: 10.1016/j.biocel.2008.05.006. Epub 2008 May 20. [PubMed:18573681 ]
  3. Guryev O, Carvalho RA, Usanov S, Gilep A, Estabrook RW: A pathway for the metabolism of vitamin D3: unique hydroxylated metabolites formed during catalysis with cytochrome P450scc (CYP11A1). Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14754-9. Epub 2003 Dec 1. [PubMed:14657394 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
inhibitor
General Function:
Vitamin d 24-hydroxylase activity
Specific Function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics.
Gene Name:
CYP1A1
Uniprot ID:
P04798
Molecular Weight:
58164.815 Da
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
inhibitor
General Function:
Steroid hydroxylase activity
Specific Function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,4-cineole 2-exo-monooxygenase.
Gene Name:
CYP2B6
Uniprot ID:
P20813
Molecular Weight:
56277.81 Da
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
inhibitor
General Function:
Steroid hydroxylase activity
Specific Function:
Responsible for the metabolism of a number of therapeutic agents such as the anticonvulsant drug S-mephenytoin, omeprazole, proguanil, certain barbiturates, diazepam, propranolol, citalopram and imipramine.
Gene Name:
CYP2C19
Uniprot ID:
P33261
Molecular Weight:
55930.545 Da
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
inhibitor
General Function:
Steroid hydroxylase activity
Specific Function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme...
Gene Name:
CYP2C8
Uniprot ID:
P10632
Molecular Weight:
55824.275 Da
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
inhibitor
General Function:
Steroid hydroxylase activity
Specific Function:
Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenyto...
Gene Name:
CYP2C9
Uniprot ID:
P11712
Molecular Weight:
55627.365 Da
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]
Kind
Protein
Organism
Human
Pharmacological action
unknown
Actions
inhibitor
General Function:
Steroid hydroxylase activity
Specific Function:
Responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants.
Gene Name:
CYP2D6
Uniprot ID:
P10635
Molecular Weight:
55768.94 Da
References
  1. Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970. Epub 2009 Nov 24. [PubMed:19934256 ]

Carriers

Kind
Protein
Organism
Human
Pharmacological action
no
General Function:
Vitamin transporter activity
Specific Function:
Involved in vitamin D transport and storage, scavenging of extracellular G-actin, enhancement of the chemotactic activity of C5 alpha for neutrophils in inflammation and macrophage activation.
Gene Name:
GC
Uniprot ID:
P02774
Molecular Weight:
52963.025 Da
References
  1. Nykjaer A, Dragun D, Walther D, Vorum H, Jacobsen C, Herz J, Melsen F, Christensen EI, Willnow TE: An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3. Cell. 1999 Feb 19;96(4):507-15. [PubMed:10052453 ]
  2. Verboven C, Rabijns A, De Maeyer M, Van Baelen H, Bouillon R, De Ranter C: A structural basis for the unique binding features of the human vitamin D-binding protein. Nat Struct Biol. 2002 Feb;9(2):131-6. [PubMed:11799400 ]
  3. Houghton LA, Vieth R: The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr. 2006 Oct;84(4):694-7. [PubMed:17023693 ]
  4. Yamamoto N, Naraparaju VR: Vitamin D3-binding protein as a precursor for macrophage activating factor in the inflammation-primed macrophage activation cascade in rats. Cell Immunol. 1996 Jun 15;170(2):161-7. [PubMed:8660814 ]
  5. Yamamoto N, Naraparaju VR: Role of vitamin D3-binding protein in activation of mouse macrophages. J Immunol. 1996 Aug 15;157(4):1744-9. [PubMed:8759764 ]
Comments
comments powered by Disqus
Drug created on June 13, 2005 07:24 / Updated on December 09, 2016 03:54